SCHEMBL4344595

SCHEMBL4344595

Cc1nc2ccccc2nc1CN

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.51
PDE10A Q9Y233 3/20 0.49
NPSR1 Q6W5P4 1/20 0.47
ALDH1A1 P00352 4/20 0.46
MAPK1 P28482 2/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 4/20 0.45
CYP1A2 P05177 3/20 0.45
KDM4E B2RXH2 2/20 0.45
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
NUDT1 P36639 1/20 0.44
GPR3 P46089 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
TSHR P16473 1/20 0.42
NQO2 P16083 1/20 0.41
GAA P10253 1/20 0.41
PDPK1 O15530 1/20 0.40
NPC1 O15118 1/20 0.40
EGFR P00533 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3735430 0.80 LMNA (0.53) LMNAPDE10ANPSR1ALDH1A1MAPK1
SCHEMBL4355754 0.78 LMNA (0.56) LMNAPDE10ANPSR1ALDH1A1MAPK1
SCHEMBL16424551 0.78 LMNA (0.51) LMNAPDE10ANPSR1ALDH1A1MAPK1
SCHEMBL14473916 0.78 LMNA (0.51) LMNAPDE10ANPSR1ALDH1A1MAPK1
SCHEMBL7074713 0.77 PDE10A (0.56) LMNAPDE10ANPSR1ALDH1A1MAPK1
SCHEMBL29364974 0.75 MAPT (0.62) ALDH1A1MAPTCYP1A2KDM4EHPGD
SCHEMBL103601 0.75 MAPT (0.62) ALDH1A1MAPTCYP1A2KDM4EHPGD
SCHEMBL22342229 0.75 ALDH1A1 (0.55) LMNAPDE10ANPSR1ALDH1A1MAPK1
SCHEMBL11328150 0.75 LMNA (0.49) LMNAPDE10ANPSR1ALDH1A1MAPK1
SCHEMBL12775683 0.75 LMNA (0.49) LMNAPDE10ANPSR1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1961733-B1 METHOD FOR SELECTIVELY PRODUCING PRIMARY AMINE COMPOUND SUMITOMO CHEMICAL CO (JP) 2014-08-20 EP disclosed
CN-101370765-B Method for selectively producing primary amine SUMITOMO CHEMICAL CO 2013-03-13 CN disclosed
US-8269044-B2 Method for selectively producing primary amine compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-09-18 US disclosed
US-20090281325-A1 METHOD FOR SELECTIVELY PRODUCING PRIMARY AMINE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-11-12 US disclosed
CN-101370765-A Method for selectively producing primary amine SUMITOMO CHEMICAL CO (JP) 2009-02-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281325-A1 METHOD FOR SELECTIVELY PRODUCING PRIMARY AMINE COMPOUND NAT1, AADAC, AOC3 LMNA 2739/4885PDE10A 1327/4885NPSR1 1257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.